| Cyd Sanchez, | |
|
1720 University Dr S Rt 1707, Fargo, ND 58103-4940 | |
| (701) 234-1728 | |
| (701) 234-1681 |
| Full Name | Cyd Sanchez |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 1720 University Dr S Rt 1707, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225419872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R41759 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
GlycoMimetics, Inc. today announced top line clinical results from a Phase 2 study of GMI-1070 in patients experiencing vaso-occlusive crisis of sickle cell disease.
An increasing number of clinical studies are pointing to a link between the autoimmune disease multiple sclerosis (MS) and the composition of microbes in the human gut, sparking new research on the gut microbiome as a potential target for MS treatment and prevention.
Zyomyx a privately held biotechnology company, has announced that the United States Patent and Trademark Office issued five new patents to the Company. With these additions, Zyomyx has further strengthened its proprietary position in the area of protein biochip technology development and commercialization.
Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.
Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, announces its annual BioCap Conference, which will take place at the Hilton Hotel, Manchester on the 29th September 2014.
› Verified 9 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
GlycoMimetics, Inc. today announced top line clinical results from a Phase 2 study of GMI-1070 in patients experiencing vaso-occlusive crisis of sickle cell disease.
An increasing number of clinical studies are pointing to a link between the autoimmune disease multiple sclerosis (MS) and the composition of microbes in the human gut, sparking new research on the gut microbiome as a potential target for MS treatment and prevention.
Zyomyx a privately held biotechnology company, has announced that the United States Patent and Trademark Office issued five new patents to the Company. With these additions, Zyomyx has further strengthened its proprietary position in the area of protein biochip technology development and commercialization.
Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.
Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, announces its annual BioCap Conference, which will take place at the Hilton Hotel, Manchester on the 29th September 2014.
› Verified 9 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
GlycoMimetics, Inc. today announced top line clinical results from a Phase 2 study of GMI-1070 in patients experiencing vaso-occlusive crisis of sickle cell disease.
An increasing number of clinical studies are pointing to a link between the autoimmune disease multiple sclerosis (MS) and the composition of microbes in the human gut, sparking new research on the gut microbiome as a potential target for MS treatment and prevention.
Zyomyx a privately held biotechnology company, has announced that the United States Patent and Trademark Office issued five new patents to the Company. With these additions, Zyomyx has further strengthened its proprietary position in the area of protein biochip technology development and commercialization.
Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.
Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, announces its annual BioCap Conference, which will take place at the Hilton Hotel, Manchester on the 29th September 2014.
› Verified 9 days ago
| Entity Name | Plains Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114479375 PECOS PAC ID: 6103108691 Enrollment ID: O20170118000392 |
News Archive
GlycoMimetics, Inc. today announced top line clinical results from a Phase 2 study of GMI-1070 in patients experiencing vaso-occlusive crisis of sickle cell disease.
An increasing number of clinical studies are pointing to a link between the autoimmune disease multiple sclerosis (MS) and the composition of microbes in the human gut, sparking new research on the gut microbiome as a potential target for MS treatment and prevention.
Zyomyx a privately held biotechnology company, has announced that the United States Patent and Trademark Office issued five new patents to the Company. With these additions, Zyomyx has further strengthened its proprietary position in the area of protein biochip technology development and commercialization.
Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.
Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, announces its annual BioCap Conference, which will take place at the Hilton Hotel, Manchester on the 29th September 2014.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cyd Sanchez, 1720 University Dr S Rt 1707, Fargo, ND 58103-4940 Ph: (701) 234-1728 | Cyd Sanchez, 1720 University Dr S Rt 1707, Fargo, ND 58103-4940 Ph: (701) 234-1728 |
News Archive
GlycoMimetics, Inc. today announced top line clinical results from a Phase 2 study of GMI-1070 in patients experiencing vaso-occlusive crisis of sickle cell disease.
An increasing number of clinical studies are pointing to a link between the autoimmune disease multiple sclerosis (MS) and the composition of microbes in the human gut, sparking new research on the gut microbiome as a potential target for MS treatment and prevention.
Zyomyx a privately held biotechnology company, has announced that the United States Patent and Trademark Office issued five new patents to the Company. With these additions, Zyomyx has further strengthened its proprietary position in the area of protein biochip technology development and commercialization.
Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.
Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, announces its annual BioCap Conference, which will take place at the Hilton Hotel, Manchester on the 29th September 2014.
› Verified 9 days ago
Ashley Heule, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-371-7635 | |
Julie Honeyman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-6355 | |
Todd D Underdahl, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 737 Broadway, Fargo, ND 58122 Phone: 701-234-6258 Fax: 701-234-7334 | |
Katie C Busker, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 737 Broadway, Fargo, ND 58122 Phone: 701-234-6258 | |
Jordan Idso, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2868 | |
Lindsey K Holter, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 | |
Joshua Keith Maliske, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2000 |